The Lupus Foundation of America (LFA) brings increased attention to the need for safer, tolerable and effective lupus treatments through its Zero in 50 campaign. Thursday, November 20, 2008 marked an unfortunate anniversary. It was 50 years ago the U.S. Food and Drug Administration (FDA) last approved a drug to specifically treat lupus.
Today, there is great cause for optimism. There are more lupus researchers and pioneers in biotech and pharmaceutical companies than ever before working to develop new treatment for lupus. We believe through continued partnerships on all fronts we can accelerate the pace of discovery and ultimately end the suffering caused by lupus. The LFA is on the front lines of this effort to advance the science and medicine of lupus and to bring down barriers that have impeded progress in lupus research.
Read more about this new campaign, read stories from people living with lupus and what 50 years without a new lupus drug means to them, and learn how you can take action.